$FBIO 4 SEC Filings

Filed On	Filing
01 Oct 2026	Form 4: Jin David, Chief Financial Officer Received 1,190 shares as a grant or award ($2.16K)
24 Jun 2026	Form 4: Jin David, Chief Financial Officer Received 400,000 shares as a grant or award
01 Apr 2026	Form 4: Jin David, Chief Financial Officer Received 2,967 shares as a grant or award ($6.46K)
20 Mar 2026	Form 4: Rosenwald Lindsay A Md, Director Received 475,424 shares as a grant or award
20 Mar 2026	Form 4: Weiss Michael S, Director Received 475,424 shares as a grant or award
06 Jan 2026	Form 4: Fortress Biotech, Inc., 10% owner · Avenue Therapeutics Inc Received 111,209 shares as a grant or award
05 Jan 2026	Form 4: Klein Dov, Director Received 27,322 shares as a grant or award
05 Jan 2026	Form 4: Harvey Jimmie, Director Received 27,322 shares as a grant or award
05 Jan 2026	Form 4: Lorenz Kevin, Director Received 27,322 shares as a grant or award
05 Jan 2026	Form 4: Fortress Biotech, Inc., 10% owner · Mustang Bio Inc Received 278,385 shares as a grant or award
05 Jan 2026	Form 4: Hoenlein Malcolm, Director Received 27,322 shares as a grant or award
05 Jan 2026	Form 4: Lobell J Jay, Director Received 27,322 shares as a grant or award
02 Oct 2025	Form 4: Jin David, Chief Financial Officer Received 2,711 shares as a grant or award ($3.55K)
01 Oct 2025	Form 4: Fortress Biotech, Inc., 10% owner · Mustang Bio Inc Received 59,334 shares as a grant or award
03 Jun 2025	Form 4: Fortress Biotech, Inc., 10% owner · Checkpoint Therapeutics, Inc. Sold 100,000 shares ($129K) · Returned 6,122,249 shares to the issuer ($25.1M) · Disposed of 700,000 CLASS A COMMON STOCK, PAR VALUE $0.0001 (Disposition to Issuer)
02 Apr 2025	Form 4: Fortress Biotech, Inc., 10% owner · Mustang Bio Inc Received 67,806 shares as a grant or award
02 Apr 2025	Form 4: Fortress Biotech, Inc., 10% owner · Avenue Therapeutics Inc Received 33,724 shares as a grant or award
01 Apr 2025	Form 4: Jin David, Chief Financial Officer Received 5,000 shares as a grant or award ($6.08K)
27 Feb 2025	Form 4: Fortress Biotech, Inc., 10% owner · Checkpoint Therapeutics, Inc. Received 18,500 shares as a grant or award
03 Jan 2025	Form 4: Lobell J Jay, Director Received 49,383 shares as a grant or award

Comments